Key result
Circulating chemerin links to obesity markers but not insulin resistance, with higher mRNA expression in women.
Why the study?
Gender- and adipose tissue-specific differences in human chemerin expression have not been well characterized in obesity.
Cross-Sectional
Circulating chemerin levels are associated with obesity markers, and its mRNA expression shows gender and fat depot-specific differential regulation.
Answers are grounded in this paper and cite their sources.
Gender and depot-specific chemerin expression differences observed; leaves open causal links to obesity phenotypes in prospective studies.
Chemerin, a recognized chemoattractant, is expressed in adipose tissue and plays a role in adipocytes differentiation and metabolism. Gender- and adipose tissue-specific differences in human chemerin expression have not been well characterized. Therefore, these differences were assessed in the present study. The body mass index (BMI) and the circulating levels of chemerin and other inflammatory, adiposity and insulin resistance markers were assessed in female and male adults of varying degree of obesity. Chemerin mRNA expression was also measured in paired subcutaneous and visceral adipose tissue samples obtained from a subset of the study subjects. Serum chemerin concentrations correlated positively with BMI and serum leptin levels and negatively with high density lipoprotein (HDL)-cholesterol levels. No correlation was found between serum chemerin concentrations and fasting glucose, total cholesterol, low density lipoprotein (LDL)-cholesterol, triglycerides, insulin, C-reactive protein or adiponectin. Similarly, no relation was observed with the homeostasis model assessment for insulin resistance (HOMA-IR) values. Gender- and adipose tissue-specific differences were observed in chemerin mRNA expression levels, with expression significantly higher in women than men and in subcutaneous than visceral adipose tissue. Interestingly, we found a significant negative correlation between circulating chemerin levels and chemerin mRNA expression in subcutaneous fat. Among the subjects studied, circulating chemerin levels were associated with obesity markers but not with markers of insulin resistance. At the tissue level, fat depot-specific differential regulation of chemerin mRNA expression might contribute to the distinctive roles of subcutaneous vs. visceral adipose tissue in human obesity.
No takes yet. Share an insight, caveat, or question.
Alfadda et al. (2012) conducted a cross-sectional in Obesity. Obesity and gender was evaluated on Correlation of serum chemerin with obesity markers and differential mRNA expression by gender and fat depot. Circulating chemerin levels were associated with obesity markers but not insulin resistance, and chemerin mRNA expression was significantly higher in women and in subcutaneous adipose tissue.
Synapse has enriched 10 related papers. Consider them for comparative context: